Lymphatic vessels in the development of tissue and organ rejection

Advances in Anatomy Embryology and Cell Biology

Volumn 214, Issue , 2014, Pages 119-141

  Hos, Deniz ^a   Cursiefen, Claus ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; CORNEA TRANSPLANTATION; GRAFT REJECTION; HUMAN; LYMPH VESSEL; LYMPHANGIOGENESIS; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CORNEAL TRANSPLANTATION; GRAFT REJECTION; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84958536533     PISSN: 03015556     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-1646-3_10     Document Type: Article

References (84)

1. Afzali, B., Lombardi, G., & Lechler, R. I. (2008). Pathways of major histocompatibility complex allorecognition. Current Opinion in Organ Transplantation, 13, 438-444
2. Albuquerque, R. J., Hayashi, T., Cho, W. G., Kleinman, M. E., Dridi, S., Takeda, A., et al. (2009). Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nature Medicine, 15, 1023-1030
3. Alitalo, K. (2011). The lymphatic vasculature in disease. Nature Medicine, 17, 1371-1380
4. Alitalo, K., Tammela, T., & Petrova, T. V. (2005). Lymphangiogenesis in development and human disease. Nature, 438, 946-953
5. Alvarez, D., Vollmann, E. H., & von Andrian, U. H. (2008). Mechanisms and consequences of dendritic cell migration. Immunity, 29, 325-342
6. Ambati, B. K., Nozaki, M., Singh, N., Takeda, A., Jani, P. D., Suthar, T., et al. (2006). Corneal avascularity is due to soluble VEGF receptor-1. Nature, 443, 993-997
7. Andrieu-Soler, C., Berdugo, M., Doat, M., Courtois, Y., BenEzra, D., & Behar-Cohen, F. (2005). Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis. Investigative Ophthalmology & Visual Science, 46, 4072-4078
8. Armstrong, L. C., & Bornstein, P. (2003). Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biology, 22, 63-71
9. Azar, D. T. (2006). Corneal angiogenic privilege: Angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Transactions of the American Ophthalmological Society, 104, 264-302
10. Bachmann, B. O., Bock, F., Wiegand, S. J., Maruyama, K., Dana, M. R., Kruse, F. E., et al. (2008). Promotion of graft survival by vascular endothelial growth factor a neutralization after highrisk corneal transplantation. Archives of Ophthalmology, 126, 71-77
11. Bachmann, B. O., Luetjen-Drecoll, E., Bock, F., Wiegand, S. J., Hos, D., Dana, R., et al. (2009). Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation. The British Journal of Ophthalmology, 93, 1075-1080
12. Bock, F., Konig, Y., Kruse, F., Baier, M., & Cursiefen, C. (2008a). Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefés Archive for Clinical and Experimental Ophthalmology, 246, 281-284
13. Bock, F., Maruyama, K., Regenfuss, B., Hos, D., Steven, P., Heindl, L. M., et al. (2013). Novel anti (lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Progress in Retinal and Eye Research, 34, 89-124
14. Bock, F., Onderka, J., Dietrich, T., Bachmann, B., Kruse, F. E., Paschke, M., et al. (2007). Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Investigative Ophthalmology & Visual Science, 48, 2545-2552
15. Bock, F., Onderka, J., Dietrich, T., Bachmann, B., Pytowski, B., & Cursiefen, C. (2008b). Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation. Graefés Archive for Clinical and Experimental Ophthalmology, 246, 115-119
16. Cera, M. R., Del Prete, A., Vecchi, A., Corada, M., Martin-Padura, I., Motoike, T., et al. (2004). Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. The Journal of Clinical Investigation, 114, 729-738
17. Chen, L., Hamrah, P., Cursiefen, C., Zhang, Q., Pytowski, B., Streilein, J. W., et al. (2004). Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nature Medicine, 10, 813-815
18. Cheng, S. F., Dastjerdi, M. H., Ferrari, G., Okanobo, A., Bower, K. S., Ryan, D. S., et al. (2012). Short-Term topical bevacizumab in the treatment of stable corneal neovascularization. American Journal of Ophthalmology, 154(940-948), e941
19. Cursiefen, C. (2007). Immune privilege and angiogenic privilege of the cornea. Chemical Immunology and Allergy, 92, 50-57
20. Cursiefen, C., Bock, F., Horn, F. K., Kruse, F. E., Seitz, B., Borderie, V., et al. (2009). GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: Interim results of a randomized phase II trial. Ophthalmology, 116, 1630-1637
21. Cursiefen, C., Cao, J., Chen, L., Liu, Y., Maruyama, K., Jackson, D., et al. (2004a). Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Investigative Ophthalmology & Visual Science, 45, 2666-2673
22. Cursiefen, C., Chen, L., Borges, L. P., Jackson, D., Cao, J., Radziejewski, C., et al. (2004b). VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. The Journal of Clinical Investigation, 113, 1040-1050
23. Cursiefen, C., Chen, L., Dana, M. R., & Streilein, J. W. (2003). Corneal lymphangiogenesis: Evidence, mechanisms, and implications for corneal transplant immunology. Cornea, 22, 273-281
24. Cursiefen, C., Chen, L., Saint-Geniez, M., Hamrah, P., Jin, Y., Rashid, S., et al. (2006a). Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proceedings of the National Academy of Sciences of the United States of America, 103, 11405-11410
25. Cursiefen, C., Kuchle, M., & Naumann, G. O. (1998). Angiogenesis in corneal diseases: Histopathologic evaluation of 254 human corneal buttons with neovascularization. Cornea, 17, 611-613
26. Cursiefen, C., Martus, P., Nguyen, N. X., Langenbucher, A., Seitz, B., & Kuchle, M. (2002a). Corneal neovascularization after nonmechanical versus mechanical corneal trephination for non-high-risk keratoplasty. Cornea, 21, 648-652
27. Cursiefen, C., Maruyama, K., Bock, F., Saban, D., Sadrai, Z., Lawler, J., et al. (2011). Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. The Journal of Experimental Medicine, 208, 1083-1092
28. Cursiefen, C., Maruyama, K., Jackson, D. G., Streilein, J. W., & Kruse, F. E. (2006b). Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea, 25, 443-447
29. Cursiefen, C., Masli, S., Ng, T. F., Dana, M. R., Bornstein, P., Lawler, J., et al. (2004c). Roles of thrombospondin-1 and-2 in regulating corneal and iris angiogenesis. Investigative Ophthalmology& Visual Science, 45, 1117-1124
30. Cursiefen, C., Schlotzer-Schrehardt, U., Kuchle, M., Sorokin, L., Breiteneder-Geleff, S., Alitalo, K., et al. (2002b). Lymphatic vessels in vascularized human corneas: Immunohistochemical investigation using LYVE-1 and podoplanin. Investigative Ophthalmology & Visual Science, 43, 2127-2135
31. Cursiefen, C., Wenkel, H., Martus, P., Langenbucher, A., Nguyen, N. X., Seitz, B., et al. (2001). Impact of short-Term versus long-Term topical steroids on corneal neovascularization after non-high-risk keratoplasty. Graefés Archive for Clinical and Experimental Ophthalmology, 239, 514-521
32. Dana, M. R. (2006). Angiogenesis and lymphangiogenesis-implications for corneal immunity. Seminars in Ophthalmology, 21, 19-22
33. Dana, M. R., Schaumberg, D. A., Kowal, V. O., Goren, M. B., Rapuano, C. J., Laibson, P. R., et al. (1995). Corneal neovascularization after penetrating keratoplasty. Cornea, 14, 604-609
34. Dana, M. R., & Streilein, J. W. (1996). Loss and restoration of immune privilege in eyes with corneal neovascularization. Investigative Ophthalmology & Visual Science, 37, 2485-2494
35. Dashkevich, A., Heilmann, C., Kayser, G., Germann, M., Beyersdorf, F., Passlick, B., et al. (2010). Lymph angiogenesis after lung transplantation and relation to acute organ rejection in humans. The Annals of Thoracic Surgery, 90, 406-411
36. Dietrich, T., Bock, F., Yuen, D., Hos, D., Bachmann, B. O., Zahn, G., et al. (2010). Cutting edge: Lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. Journal of Immunology, 184, 535-539
37. Dietrich, T., Onderka, J., Bock, F., Kruse, F. E., Vossmeyer, D., Stragies, R., et al. (2007). Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. The American Journal of Pathology, 171, 361-372
38. Ferrari, G., Dastjerdi, M. H., Okanobo, A., Cheng, S. F., Amparo, F., Nallasamy, N., et al. (2013). Topical ranibizumab as a treatment of corneal neovascularization. Cornea, 32(7), 992-997
39. Forster, R., Davalos-Misslitz, A. C., & Rot, A. (2008). CCR7 and its ligands: Balancing immunity and tolerance. Nature Reviews. Immunology, 8, 362-371
40. Forster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Muller, I., Wolf, E., et al. (1999). CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell, 99, 23-33
41. Gould, D. S., & Auchincloss, H., Jr. (1999). Direct and indirect recognition: The role of MHC antigens in graft rejection. Immunology Today, 20, 77-82
42. Hos, D., Bachmann, B., Bock, F., Onderka, J., & Cursiefen, C. (2008a). Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis. Experimental Eye Research, 87, 427-432
43. Hos, D., Bock, F., Dietrich, T., Onderka, J., Kruse, F. E., Thierauch, K. H., et al. (2008b). Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-Tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation. Investigative Ophthalmology & Visual Science, 49, 1836-1842
44. Hos, D., Regenfuss, B., Bock, F., & Cursiefen, C. (2011). Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis. Investigative Ophthalmology & Visual Science, 52, 5778-5785
45. Ishii, E., Shimizu, A., Kuwahara, N., Arai, T., Kataoka, M., Wakamatsu, K., et al. (2010). Lymphangiogenesis associated with acute cellular rejection in rat liver transplantation. Transplantation Proceedings, 42, 4282-4285
46. Johnson, L. A., Clasper, S., Holt, A. P., Lalor, P. F., Baban, D., & Jackson, D. G. (2006). An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. The Journal of Experimental Medicine, 203, 2763-2777
47. Johnson, L. A., & Jackson, D. G. (2010). Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrin-mediated dendritic cell transmigration. International Immunology, 22, 839-849
48. Källskog, O., Kampf, C., Andersson, A., Carlsson, P. O., Hansell, P., Johansson, M., et al. (2006). Lymphatic vessels in pancreatic islets implanted under the renal capsule of rats. American Journal of Transplantation, 6, 680-686
49. Karpanen, T., & Alitalo, K. (2008). Molecular biology and pathology of lymphangiogenesis. Annual Review of Pathology, 3, 367-397
50. Kerjaschki, D., Huttary, N., Raab, I., Regele, H., Bojarski-Nagy, K., Bartel, G., et al. (2006). Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nature Medicine, 12, 230-234
51. Kerjaschki, D., Regele, H. M., Moosberger, I., Nagy-Bojarski, K., Watschinger, B., Soleiman, A., et al. (2004). Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. Journal of the American Society of Nephrology, 15, 603-612
52. Koenig, Y., Bock, F., Kruse, F. E., Stock, K., & Cursiefen, C. (2012). Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: Fine-needle vessel coagulation combined with anti-VEGFs. Cornea, 31, 887-892
53. Lakkis, F. G., Arakelov, A., Konieczny, B. T., & Inoue, Y. (2000). Immunologic ignorance of vascularized organ transplants in the absence of secondary lymphoid tissue. Nature Medicine, 6, 686-688
54. Lin, H. C., Chang, J. H., Jain, S., Gabison, E. E., Kure, T., Kato, T., et al. (2001). Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment. Investigative Ophthalmology & Visual Science, 42, 2517-2524
55. Lindquist, R. L., Shakhar, G., Dudziak, D., Wardemann, H., Eisenreich, T., Dustin, M. L., et al. (2004). Visualizing dendritic cell networks in vivo. Nature Immunology, 5, 1243-1250
56. Liu, Z., Colovai, A. I., Tugulea, S., Reed, E. F., Fisher, P. E., Mancini, D., et al. (1996). Indirect recognition of donor HLA-DR peptides in organ allograft rejection. The Journal of Clinical Investigation, 98, 1150-1157
57. Luther, S. A., Tang, H. L., Hyman, P. L., Farr, A. G., & Cyster, J. G. (2000). Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proceedings of the National Academy of Sciences of the United States of America, 97, 12694-12699
58. Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., et al. (2001). Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature, 414, 550-554
59. Martinez-Corral, I., Olmeda, D., Dieguez-Hurtado, R., Tammela, T., Alitalo, K., & Ortega, S. (2012). In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis. Proceedings of the National Academy of Sciences of the United States of America, 109, 6223-6228
60. Martin-Fontecha, A., Sebastiani, S., Hopken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., et al. (2003). Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming. The Journal of Experimental Medicine, 198, 615-621
61. Maruyama, K., Ii, M., Cursiefen, C., Jackson, D. G., Keino, H., Tomita, M., et al. (2005). Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. The Journal of Clinical Investigation, 115, 2363-2372
62. Nakao, S., Zandi, S., Faez, S., Kohno, R., & Hafezi-Moghadam, A. (2012). Discontinuous LYVE-1 expression in corneal limbal lymphatics: Dual function as microvalves and immunological hot spots. FASEB Journal, 26, 808-817
63. Niederkorn, J. Y. (2010). High-risk corneal allografts and why they lose their immune privilege. Current Opinion in Allergy and Clinical Immunology, 10, 493-497
64. Nykanen, A. I., Sandelin, H., Krebs, R., Keranen, M. A., Tuuminen, R., Karpanen, T., et al. (2010). Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts. Circulation, 121, 1413-1422.
65. Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., et al. (2004). CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity, 21, 279-288
66. Palin, N. K., Savikko, J., & Koskinen, P. K. (2013). Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury. Transplant International, 26, 195-205
67. Philipp, W., Speicher, L., & Humpel, C. (2000). Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Investigative Ophthalmology & Visual Science, 41, 2514-2522
68. Pietra, B. A., Wiseman, A., Bolwerk, A., Rizeq, M., & Gill, R. G. (2000). CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. The Journal of Clinical Investigation, 106, 1003-1010
69. Potente, M., Gerhardt, H., & Carmeliet, P. (2011). Basic and therapeutic aspects of angiogenesis. Cell, 146, 873-887
70. Randolph, G. J., Angeli, V., & Swartz, M. A. (2005). Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nature Reviews. Immunology, 5, 617-628
71. Regenfuss, B., Onderka, J., Bock, F., Hos, D., Maruyama, K., & Cursiefen, C. (2010). Genetic heterogeneity of lymphangiogenesis in different mouse strains. The American Journal of Pathology, 177, 501-510
72. Roozendaal, R., Mebius, R. E., & Kraal, G. (2008). The conduit system of the lymph node. International Immunology, 20, 1483-1487
73. Salmi, M., & Jalkanen, S. (2005). Cell-surface enzymes in control of leukocyte trafficking. Nature Reviews. Immunology, 5, 760-771
74. Salven, P., Mustjoki, S., Alitalo, R., Alitalo, K., & Rafii, S. (2003). VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood, 101, 168-172
75. Sano, Y., Ksander, B. R., & Streilein, J. W. (1995). Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-Associated immune deviation induction. Investigative Ophthalmology & Visual Science, 36, 2176-2185
76. Singh, N., Tiem, M., Watkins, R., Cho, Y. K., Wang, Y., Olsen, T., et al. (2013). Soluble vascular endothelial growth factor receptor-3 is essential for corneal alymphaticity. Blood, 121(20), 4242-4249
77. Steven, P., Bock, F., Huttmann, G., & Cursiefen, C. (2011). Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vessels. PloS One, 6, e26253
78. Streilein, J. W., Yamada, J., Dana, M. R., & Ksander, B. R. (1999). Anterior chamber-Associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplantation Proceedings, 31, 1472-1475
79. Tammela, T., & Alitalo, K. (2010). Lymphangiogenesis: Molecular mechanisms and future promise. Cell, 140, 460-476
80. Truong, T., Altiok, E., Yuen, D., Ecoiffier, T., & Chen, L. (2011). Novel characterization of lymphatic valve formation during corneal inflammation. PloS One, 6, e21918
81. Xi, X., McMillan, D. H., Lehmann, G. M., Sime, P. J., Libby, R. T., Huxlin, K. R., et al. (2011). Ocular fibroblast diversity: Implications for inflammation and ocular wound healing. Investigative Ophthalmology & Visual Science, 52, 4859-4865
82. Yamagami, S., & Dana, M. R. (2001). The critical role of lymph nodes in corneal alloimmunization and graft rejection. Investigative Ophthalmology & Visual Science, 42, 1293-1298
83. Yamagami, S., Dana, M. R., & Tsuru, T. (2002). Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation. Cornea, 21, 405-409
84. Yin, N., Zhang, N., Xu, J., Shi, Q., Ding, Y., & Bromberg, J. S. (2011). Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival. Transplantation, 92, 25-30